About Drs Alexia
The company has 8 employees. Drs Alexia offers products and services including Shellking OT and Hiclogen T.
- Employees 8
- SectorsHealthcare
- Email••••••••
- Legal Name Drs Alexia Pharma Private Limited
- Date of Incorporation 28 May, 2014
- Jurisdiction Thrissur, Kerala, India
- Annual Revenue₹7.96 Cr
FY 2025 · +3% YoY
- Net Profit₹10.9 Lakh
FY 2025 · 1% margin
- EBITDA₹15.6 Lakh
FY 2025 · 2% margin
- Employee Count8
Associated legal entities of Drs Alexia
Drs Alexia operates through Drs Alexia Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Drs Alexia Pharma Private Limited CIN U52310KL2014PTC036657 | Active | 28 May 2014 | Thrissur, Kerala | ₹8.0 Cr | 8 | 10 | View details |
Products & Services of Drs Alexia
Drs Alexia offers a comprehensive portfolio of products and services, including Shellking OT and Hiclogen T.
Shellking OT Tab is provided as a pharmaceutical product in the company's offerings.
Hiclogen T Tab is included in the pharmaceutical products marketed by Drs Alexia.
Board of directors of Drs Alexia Pharma Private Limited (Drs Alexia)
Drs Alexia Pharma Private Limited is the primary company behind Drs Alexia. The board of Drs Alexia Pharma Private Limited currently have 10 directors; the longest-serving is Chandran Parlikkatt Narayanan, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandran Parlikkatt Narayanan DIN 01200962 | Managing Director | 28 May 2014 | 12 yrs 4 mo | Drs Alexia Pharma Private Limited |
| Shiji Sudarsanan Krishnaveni DIN 06847586 | Director | 28 May 2014 | 12 yrs 4 mo | Drs Alexia Pharma Private Limited |
| Chandrika Mullakkal Velayudhan DIN 06847568 | Director | 28 May 2014 | 12 yrs 4 mo | Drs Alexia Pharma Private Limited |
| Umesh DIN 06847616 | Director | 28 May 2014 | 12 yrs 4 mo | Drs Alexia Pharma Private Limited |
| Manoj Vijayan DIN 06847578 | Director | 28 May 2014 | 12 yrs 4 mo | Drs Alexia Pharma Private Limited |
| Velappan Nadar Thanuvan Nadar DIN 07842286 | Director | 23 Jan 2017 | 9 yrs 8 mo | Drs Alexia Pharma Private Limited |
| Thamarassery Megha Mohanan DIN 07842200 | Director | 23 Jan 2017 | 9 yrs 8 mo | Drs Alexia Pharma Private Limited |
| Suja DIN 07842284 | Director | 23 Jan 2017 | 9 yrs 8 mo | Drs Alexia Pharma Private Limited |
| Karipparambil Athira Ramakrishnan DIN 07842248 | Director | 23 Jan 2017 | 9 yrs 8 mo | Drs Alexia Pharma Private Limited |
| Sabitha Balan Mathramkott DIN 07842222 | Director | 23 Jan 2017 | 9 yrs 8 mo | Drs Alexia Pharma Private Limited |
Financials of Drs Alexia
Figures of Drs Alexia Pharma Private Limited, the primary company behind Drs Alexia, for FY 2025. Revenue was ₹7.96 Cr (+3% year on year). Net profit was ₹10.9 Lakh (1% margin). EBITDA was ₹15.6 Lakh (2% margin). Revenue has grown at a compounded annual rate of +3% over three years and +5% over five years.
- ₹7.96 CrRevenue · FY 2025 · +3% YoY
- ₹10.9 LakhNet profit · 1% margin
- ₹15.6 LakhEBITDA · 2% margin
- ₹75 LakhPaid-up capital
- 8Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Drs Alexia Pharma Private Limited are on its company page.
Detailed financial statements for Drs Alexia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Drs Alexia
10 companies that operate in the same segment as Drs Alexia (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Drs Alexia
Drs Alexia has 8 employees.
The primary company behind Drs Alexia, Drs Alexia Pharma Private Limited, reported revenue of ₹7.96 Cr for FY 2025, up 3% year on year.
Drs Alexia was established in February 2012 as an emerging pharmaceutical marketing company that provides quality medicines in the Indian market. Contractual ties with reputed manufacturers are maintained for developing and manufacturing prescribed molecules, while teams are engaged in identifying doctors needs and ensuring stringent quality measures in ingredient procurement, processing, and packing. Availability of medicines wherever required is emphasized to promote health to all mankind, with directors consisting of NRI and medical representatives.
Drs Alexia offers Shellking OT and Hiclogen T.
Drs Alexia operates through Drs Alexia Pharma Private Limited.
The legal entities of Drs Alexia currently have 10 directors, including Chandran Parlikkatt Narayanan, Velappan Nadar Thanuvan Nadar, Thamarassery Megha Mohanan and others.